ESR1 and breast cancer: Luminal A is the most common subtype of breast cancer, mainly manifested as estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER-2) negative, low Ki-67 (2), accounting for 50.6–71% of all breast cancer patients (3, 4).